Risk factors for cardiovascular disease in systemic lupus erythematosus

Area of Science:

• Rheumatology
• Cardiology
• Immunology

Background:

• Cardiovascular disease (CVD) is a significant concern in patients with systemic lupus erythematosus (SLE).
• Understanding the specific risk factors for CVD in SLE is crucial for patient management.

Purpose of the Study:

• To determine the prevalence of traditional and nontraditional CVD risk factors in SLE patients with and without existing CVD.
• To compare these risk factors against a general population control group.

Main Methods:

• Comparative study involving three groups: SLE patients with CVD (SLE cases), SLE patients without CVD (SLE controls), and population controls.
• Measurement of common carotid intima-media thickness (IMT) via ultrasound as a surrogate for atherosclerosis.
• Analysis of plasma biomarkers including oxidized LDL (OxLDL), autoantibodies to OxLDL, triglycerides, HDL-cholesterol, lipoprotein(a), alpha-1-antitrypsin, lupus anticoagulant, and homocysteine levels.

Main Results:

• SLE cases showed significantly increased IMT compared to both SLE controls and population controls.
• SLE cases exhibited higher levels of OxLDL, autoantibodies to OxLDL, triglycerides, lipoprotein(a), alpha-1-antitrypsin, lupus anticoagulant, and homocysteine.
• SLE cases also had a higher prevalence of osteoporosis and a greater cumulative prednisolone dose compared to SLE controls.
• No significant differences were observed in disease duration, smoking, blood pressure, BMI, or diabetes mellitus between SLE cases and SLE controls.

Conclusions:

• A distinct set of CVD risk factors differentiates SLE patients with CVD from those without and from the general population.
• These identified risk factors could potentially be used to stratify SLE patients by CVD risk.
• Prospective studies are needed to confirm these findings and optimize CVD risk management in SLE patients.